![Martin Diggle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Martin Diggle
Direttore/Membro del Consiglio presso
PROTEOME SCIENCES PLC
Profilo
Martin Henry Diggle founded Vulpes Investment Management Ltd., where he is working as Director & Partner from 2015.
Mr. Diggle also currently works at Vulpes Life Sciences Fund, as Chairman, Proteome Sciences Plc, as Non-Executive Director from 2014, Oxford BioDynamics Plc, as Non-Executive Director from 2026, and Vulpes Ventures, as Portfolio Manager.
Mr. Diggle also formerly worked at Oxford Biomedica Plc, as Non-Independent Non-Executive Director from 2012 to 2021, Brunswick UBS, as Director & Partner, Scancell Holdings Plc, as Non-Executive Director, Leucid Bio Ltd., as Director, and Chronos Therapeutics Ltd., as Non-Executive Director.
Mr. Diggle received his graduate degree from the University of Oxford.
Posizioni attive di Martin Diggle
| Società | Posizione | Inizio |
|---|---|---|
| PROTEOME SCIENCES PLC | Direttore/Membro del Consiglio | 16/10/2014 |
| OXFORD BIODYNAMICS PLC | Direttore/Membro del Consiglio | 15/04/2026 |
Vulpes Investment Management Ltd.
 Vulpes Investment Management Ltd. Investment ManagersFinance Provides investment advice | Direttore/Membro del Consiglio | 27/03/2015 |
Vulpes Investment Management Pte Ltd. (Venture Capital)
 Vulpes Investment Management Pte Ltd. (Venture Capital) Investment ManagersFinance Vulpes Ventures invests in companies located in Southeast Asia, Australia and New Zealand. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Investitore di Private Equity | - |
Vulpes Life Sciences Fund
 Vulpes Life Sciences Fund Investment Trusts/Mutual FundsMiscellaneous Acts as Hedge Fund | Presidente | - |
Precedenti posizioni note di Martin Diggle
| Società | Posizione | Fine |
|---|---|---|
| OXFORD BIOMEDICA PLC | Direttore/Membro del Consiglio | 03/02/2021 |
Brunswick UBS
 Brunswick UBS Investment Banks/BrokersFinance Operates as a investment bank | Direttore/Membro del Consiglio | 01/01/2003 |
Leucid Bio Ltd.
 Leucid Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biotech company that develops next generation CAR-T therapy | Direttore/Membro del Consiglio | - |
| SCANCELL HOLDINGS PLC | Direttore/Membro del Consiglio | - |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
Formazione di Martin Diggle
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
23
Relazioni di 1° grado
11
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 11 |
|---|---|
Proteome Sciences Plc
 Proteome Sciences Plc Medical SpecialtiesHealth Technology Develops medical diagnostics used to identify specific diseases | Health Technology |
Oxford Biomedica Plc
 Oxford Biomedica Plc BiotechnologyHealth Technology Operates as a contract development and manufacturing organization which provides viral vectors to pharmaceutical and biotechnology clients in cell and gene therapy fields | Health Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Brunswick UBS
Brunswick UBS Investment Banks/BrokersFinance Operates as a investment bank | Finance |
Scancell Holdings Plc
 Scancell Holdings Plc BiotechnologyHealth Technology Develops therapeutic cancer vaccines | Health Technology |
Oxford BioDynamics Plc
 Oxford BioDynamics Plc BiotechnologyHealth Technology Discovers and develops novel biomarkers | Health Technology |
Vulpes Investment Management Ltd.
Vulpes Investment Management Ltd. Investment ManagersFinance Provides investment advice | Finance |
Vulpes Life Sciences Fund
Vulpes Life Sciences Fund Investment Trusts/Mutual FundsMiscellaneous Acts as Hedge Fund | Miscellaneous |
Chronos Therapeutics Ltd.
 Chronos Therapeutics Ltd. BiotechnologyHealth Technology Develops therapies in degenerative and behavioral brain diseases | Health Technology |
Vulpes Investment Management Pte Ltd. (Venture Capital)
Vulpes Investment Management Pte Ltd. (Venture Capital) Investment ManagersFinance Vulpes Ventures invests in companies located in Southeast Asia, Australia and New Zealand. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
Leucid Bio Ltd.
Leucid Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biotech company that develops next generation CAR-T therapy | Commercial Services |
